Allarity Therapeutics Europe ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS (CVR number: 34623562) is a company from RUDERSDAL. The company recorded a gross profit of -44548 kDKK in 2024. The operating profit was -396.8 mDKK, while net earnings were -393.8 mDKK. The profitability of the company measured by Return on Assets (ROA) was -138.7 %, which can be considered poor and Return on Equity (ROE) was -381.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -94.6 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Allarity Therapeutics Europe ApS's liquidity measured by quick ratio was 0 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | |||||
| Gross profit | -13 155.00 | -79 617.00 | -42 967.00 | -49 354.00 | -44 548.00 |
| EBIT | -16 909.00 | -79 974.00 | - 170 425.00 | -55 811.00 | - 396 790.00 |
| Net earnings | -18 557.00 | -76 279.00 | - 142 438.00 | -48 735.00 | - 393 818.00 |
| Shareholders equity total | - 147 061.00 | 386 284.00 | 243 758.00 | 195 023.00 | - 198 795.00 |
| Balance sheet total (assets) | 38 172.00 | 498 792.00 | 365 943.00 | 362 236.00 | 11 249.00 |
| Net debt | 172 122.00 | 5 004.00 | 66 545.00 | 102 937.00 | 163 991.00 |
| Profitability | |||||
| EBIT-% | |||||
| ROA | -5.6 % | -11.4 % | -39.4 % | -14.8 % | -138.7 % |
| ROE | -47.3 % | -35.9 % | -45.2 % | -22.2 % | -381.8 % |
| ROI | -6.0 % | -12.7 % | -44.3 % | -17.0 % | -167.0 % |
| Economic value added (EVA) | -16 454.58 | - 113 507.86 | - 162 147.54 | -66 444.40 | - 395 174.19 |
| Solvency | |||||
| Equity ratio | -79.4 % | 77.4 % | 66.6 % | 53.8 % | -94.6 % |
| Gearing | -117.1 % | 5.2 % | 28.2 % | 52.9 % | -82.8 % |
| Relative net indebtedness % | |||||
| Liquidity | |||||
| Quick ratio | 1.3 | 0.5 | 0.1 | 0.1 | 0.0 |
| Current ratio | 1.3 | 0.5 | 0.1 | 0.1 | 0.0 |
| Cash and cash equivalents | 100.00 | 15 015.00 | 2 316.00 | 302.00 | 575.00 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | |||||
| Net working capital % | |||||
| Credit risk | |||||
| Credit rating | B | BBB | BBB | BBB | C |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.